Company news
Vivani Medical, Inc. news in 2026
Vivani Medical, Inc.'s news releases, calls and decks from 2026, newest first.
Vivani Medical Announces Private Placement Equity Financing
November 16, 2026
Vivani Medical Announces Positive Top-Line Results from SLIM-1™, a First in Human Phase 1 Trial of NPM-139 (semaglutide implant) and Wegovy (weekly semaglutide injections) in Obese and Overweight Subjects
November 12, 2026
Vivani Medical Reports Third Quarter 2026 Financial Results and Provides Business Update
November 11, 2026
Vivani Medical Announces Participation in Upcoming Investor Conferences
October 12, 2026
Vivani Medical Announces Participation in Upcoming Investor Conferences
September 3, 2026
Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update
August 13, 2026
Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
August 6, 2026
Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026
July 14, 2026
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
July 7, 2026
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
July 1, 2026
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker
June 26, 2026
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management
June 25, 2026
Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention
June 22, 2026
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026
May 28, 2026
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
May 13, 2026
Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 25, 2026
Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026
January 29, 2026
Vivani Medical, Inc. Announces Closing of Common Stock Offering
January 27, 2026
Vivani Medical, Inc. Announces Pricing of Common Stock Offering
January 25, 2026
Vivani Subsidiary Cortigent to Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026
January 22, 2026
Decks in 2026
- Investor Presentation (November 2026)
Investor deck · 35 slides · Nov 16, 2026
- Investor Presentation (November 2026)
Investor deck · 29 slides · November 2026
- Investor Presentation (October 2026)
Investor deck · 28 slides · October 2026
- Investor Presentation (August 2026)
Investor deck · 29 slides · Aug 17, 2026
- Investor Presentation (July 2026)
Investor deck · 18 slides · Jul 16, 2026
- Investor Presentation (June 2026)
Investor deck · 28 slides · Jun 4, 2026